Influenza Vaccine Availability Tracking System — IVATS

Information for the 2016–2017 influenza season

The Summit regularly posts updated information to IVATS. A resource for healthcare settings looking to purchase influenza vaccine, IVATS contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Ongoing updates are being made and will continue to be made throughout the 2016–2017 influenza vaccination season. Keep checking back.

Live attenuated influenza vaccine (LAIV4; FluMist by AstraZeneca) is not recommended by CDC’s Advisory Committee on Immunization Practices for use in the U.S. during the 2016-17 influenza season. Because LAIV4 is still a licensed vaccine that is available through several distributors listed on the IVATS spreadsheet, some providers might elect to use it. Those healthcare providers who do purchase LAIV4 must communicate certain information to patients when considering and discussing LAIV4 as an option (see http://www.izsummitpartners.org/ivats/LAIV4_Info_for_HCP_2016-17.pdf).


CLINICIANS: LOOKING FOR VACCINE?

Clinicians: IVATS can help you find influenza vaccine
ACCESS IVATS SPREADSHEET

 


DISTRIBUTORS AND MANUFACTURERS

For distributors/manufacturers with wholesale vaccine stock
IVATS REPORTING FORM

 


Disclaimer: Please note that all information in IVATS is provided by wholesale distributors or manufacturers on a voluntary basis. IVATS is not intended to endorse or promote one wholesale distributor’s or manufacturer’s product over another, and all licensed, wholesale distributors or manufacturers are welcome and encouraged to enroll.